Leorah Ross
Amgen (United States)(US)
Publications by Year
Research Areas
Lysosomal Storage Disorders Research, Carbohydrate Chemistry and Synthesis, Glycosylation and Glycoproteins Research, Hemoglobinopathies and Related Disorders, Blood groups and transfusion
Most-Cited Works
- → Angiopoietin-1 protects the adult vasculature against plasma leakage(2000)1,284 cited
- Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model.(2003)
- → Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia(2024)157 cited
- → Effect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1(2015)154 cited
- → Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial(2015)151 cited
- → Eliglustat, an investigational oral therapy for Gaucher disease type 1: Phase 2 trial results after 4 years of treatment(2014)83 cited
- → Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial(2025)37 cited
- → ENGAGE — A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in adults with Gaucher disease type 1: Results after 18months(2015)11 cited
- → ENCORE, a randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients stabilized on enzyme replacement therapy: 24-month results(2015)8 cited